CHERYL ROCHE: Open Payments
NPI 1326329921 · JACKSONVILLE BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,175 in 139 payments from 17 companies in 2025. Trend: 2023 $1,328 · 2024 $1,855 · 2025 $3,175
Food & beverage: $3,175
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $701 |
| Madrigal Pharmaceuticals | 25 | $603 |
| Ipsen Biopharmaceuticals, Inc | 9 | $338 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $234 |
| Janssen Biotech, Inc. | 8 | $189 |
| Phathom Pharmaceuticals, Inc. | 7 | $183 |
| Lilly USA, LLC | 7 | $155 |
| Regeneron Healthcare Solutions, Inc. | 6 | $152 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $145 |
| GENZYME CORPORATION | 5 | $103 |
Products named: REZDIFFRA, RINVOQ, IQIRVO, DUPIXENT, ENTYVIO, TREMFYA, VOQUEZNA, SKYRIZI.
Industry payments across FL — which companies pay providers there.
